The Director of Integrated Specialty Practices leads business development for specialty networks to drive oncology diagnostic and therapeutic solutions. This role involves building strategic partnerships, managing cross-functional teams, and executing multi-year strategies to exceed corporate financial goals.
The CMC Program Lead will coordinate and deliver CMC strategies for radiopharmaceutical drug candidates, ensuring readiness for commercial viability and market expansion. They will facilitate cross-functional teams and manage relationships with external CDMO/CMO partners to drive project objectives.
The Senior Clinical Project Manager serves as the primary sponsor operational lead, driving cross-functional alignment and overseeing clinical trials from start-up through closeout. They are responsible for managing CROs, vendors, study budgets, timelines, and ensuring compliance with regulatory standards and quality protocols.
The Manager, Regulatory Affairs (Clinical Labeling) is responsible for the development, maintenance, and oversight of investigational medicinal product labeling for global clinical trials. This role ensures compliance with global regulatory requirements while partnering with cross-functional teams to support supply chain execution and study timelines.
The Logistics Coordinator provides transactional support for daily logistics operations, including preparing shipping documentation and coordinating with freight providers. They are responsible for monitoring shipments in transit, managing documentation, and serving as an escalation point for logistics issues.
The Clinical Supply Chain Specialist manages the procurement, storage, and distribution of clinical trial materials to ensure timely delivery to sites. They also maintain inventory levels, monitor vendor performance, and ensure all activities comply with regulatory standards like GMP and GDP.
Author and manage CMC sections of global regulatory submissions, including eCTD Module 2.3 and Module 3 documents for development, commercialization, and post-approval programs. Collaborate across functions to assess manufacturing changes, maintain regulatory compliance, identify risks, and develop mitigation plans.
The Associate Director will monitor, analyze, and interpret global regulatory developments to ensure company compliance and strategic positioning. They will also provide actionable insights to cross-functional stakeholders and lead regulatory intelligence initiatives.
The Manager, Regulatory Affairs (Ad-Promo) provides strategic and tactical regulatory advice for advertising and promotional materials across global markets. They manage regulatory reviews, coordinate health authority submissions, and ensure compliance with local laws and internal policies.
The Associate Director will monitor, analyze, and interpret global regulatory developments to ensure company compliance and strategic positioning. They will also provide actionable insights to cross-functional stakeholders and lead regulatory intelligence initiatives.
The Senior Manager oversees regulatory activities for early-stage assets, planning and executing global strategies from IND/CTA through registration. They also manage health authority interactions and provide regulatory guidance to cross-functional project teams.
The Clinical Data Manager is responsible for ensuring the integrity, accuracy, and regulatory compliance of clinical trial data throughout the study lifecycle. They will oversee EDC development, manage data cleaning activities, and coordinate with external vendors to meet project timelines.
Drive sales growth across the assigned territory by identifying new business opportunities, executing sales plans, and managing relationships with healthcare clients. Promote radiopharmaceutical products through clinical presentations and training, while tracking sales activity, analyzing performance, and complying with company and regulatory requirements.
The VP of Medical Affairs will define and execute the medical strategy for the Americas, overseeing operations, budget, and tactical execution across the company's oncology portfolio. They will lead a team of Medical Directors and field staff while fostering collaborations with key opinion leaders and internal stakeholders to support clinical trials and product launches.
Lead the generation and translation of economic and outcomes evidence across diagnostic and therapeutic products, including clinical trial integration, real-world evidence studies, registries, economic models, and payer-focused reports. Support payer and policy engagements, develop evidence packages for CMS coverage decisions, and advise cross-functional teams on evidence strategy and product value narratives.
The Theranostics Specialist will lead the strategic onboarding of new imaging sites and ensure the successful adoption of Telix radiopharmaceuticals. This role involves driving cross-functional collaboration, optimizing site workflows, and executing field activities to support product launches and HCP education.
The Director will lead and scale the national Theranostics Specialist team to provide technical application support and ensure successful adoption of radiopharmaceutical products. This role involves overseeing strategy, site onboarding, workflow optimization, and cross-functional collaboration to drive commercial performance and launch execution.
The Assistant Director leads legal operations, technology enablement, and contracting infrastructure to scale the legal department and reduce reliance on external counsel. This role acts as a strategic bridge between legal and enterprise functions, implementing AI-driven workflows and process improvements.
The Senior Clinical Project Manager is responsible for the successful execution of national and global clinical trials from protocol conception through to study closeout. This includes managing trial timelines, budgets, vendor relationships, and ensuring compliance with quality standards and regulatory requirements.
The Associate Director will lead global regulatory activities for clinical and commercial registrations, managing the PSMA franchise portfolio. This role involves developing regulatory strategies, overseeing submissions, and ensuring compliance across international health authorities.
The Theranostics Specialist will serve as a field-based expert to oversee the strategic onboarding of imaging sites and ensure the successful adoption of Telix radiopharmaceuticals. This role involves driving cross-functional collaboration, optimizing site workflows, and executing field activities to support product launches and HCP education.
The Medical Science Liaison will serve as a field-based expert responsible for scientific exchange and building peer-to-peer relationships with neuro-oncology experts. They will also support clinical trial site engagement, generate actionable medical insights, and deliver scientific presentations to support the neuro-oncology portfolio.
The Medical Science Liaison serves as a field-based clinical expert responsible for scientific exchange and building relationships with key opinion leaders in oncology and related fields. They also support clinical development programs, collect field insights, and represent Medical Affairs at scientific congresses and meetings.
The Director will lead the commercial vision and lifecycle strategy for the late-stage PSMA imaging portfolio, serving as a strategic bridge between product development and regional commercial teams. They are responsible for driving high-impact commercial strategy, managing business cases, and ensuring successful launch readiness across global markets.
The Senior Director leads the global strategy, governance, and performance management of regional quality programs to ensure internal sites meet regulatory and business requirements. They oversee regional quality teams, drive continuous improvement initiatives, and serve as the primary escalation point for quality issues.
The Project Manager will oversee the planning, execution, and closure of medium to high-priority programs, ensuring alignment with strategic business objectives. Responsibilities include managing budgets, schedules, and cross-functional teams while maintaining accurate project data and mitigating risks.
Lead the Development Quality function to support radiopharmaceutical programs from early clinical development through registration-readiness. Establish QMS elements and serve as the primary quality interface with regulatory agencies, CDMOs, and clinical supply partners.
The intern will support the Supplier Quality team by developing new Quality Agreement templates and defining sustainable execution processes. They will also create work instructions and establish a schedule for periodic reviews with suppliers and stakeholders.
Drive sales and maintain strong client relationships within the assigned territory to promote radiopharmaceutical products. Responsibilities include prospecting new business, managing existing accounts, and conducting product training sessions.
Lead the development of a molecularly targeted radiation therapy through Phase 2 clinical trials. Manage cross-functional teams to execute drug development plans, budgets, and target product profiles for oncology and rare diseases.
Lead the strategic development and delivery of turnkey service solutions for PET scanner installations and radiopharmacy infrastructure. Manage the full client engagement lifecycle, from solution design and financial planning to operational execution and regulatory compliance.
Lead technical transfers and manufacturing activities for radiopharmaceutical drug substances and products, including formulation and fill/finish. Provide technical support for batch manufacturing and manage collaborations with external CDMOs to ensure regulatory compliance.
The Global Product Development Lead will own and drive the global development of late-stage radiopharmaceutical compounds for therapeutic oncology. This role involves cross-functional leadership across clinical, regulatory, CMC, and commercial teams to ensure program milestones and regulatory approvals are met.
You will be supporting the international roll-out of an approved prostate cancer imaging agent and helping to advance the portfolio of late clinical-stage products. The focus is on addressing significant unmet needs in oncology and rare diseases.
